Associate Professor Bernard Flynn: Ledger

Stories naming Associate Professor Bernard Flynn. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Founder	Ankere Therapeutics	Brandon Capital portfolio, Brandon BioCatalyst portfolio

Seed $10m

Australian collaboration and AU$10m investment fuels Ankere Therapeutics’ efforts to target inflammatory lung conditions

Biotech startup Ankere Therapeutics launches with a $10 million seed round co-led by IP Group and Brandon Capital to develop inflammatory lung disease therapies, building on research from Monash and UniSA scientists.

Also Brandon Capital portfolio·Startup Daily·@AuManufacturing

Associate Professor Bernard Flynn

Roles

Coverage

Australian collaboration and AU$10m investment fuels Ankere Therapeutics’ efforts to target inflammatory lung conditions